HNST
The Honest Company, Inc.
HNST offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over HNST overall, supported by stronger valuation and lower modeled downside.
HNST Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
HNST's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
HNST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7x | $4.80 | — |
| Cheap | 41x | $28.21 | +488% |
| Fair | 45x | $31.17 | +549% |
| Forward | 60x | $4.80 | — |
| Expensive | 78x | $53.97 | +1024% |
Historical ranges are pointers, not guarantees.
HNST has the edge over NKE in the historical PE scenario, which offers more potential upside but is not a forecast.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
HNST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
HNST has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
HNST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | -88% |
| Q3 2026 | $0.69 | +1050% |
| Q2 2026 | -$0.11 | -320% |
| Q1 2026 | -$0.17 | -$0.15 |
| Q4 2025 | -$0.14 | -$0.08 |
| Q3 2025 | $0.06 | +$0.10 |
| Q2 2025 | $0.05 | +$0.18 |
| Q1 2025 | -$0.02 | +$0.21 |
| Q4 2024 | -$0.06 | +$0.36 |
HNST has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
HNST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.6M | -8.6% |
| Q2 2026 | $83.3M | -11% |
| Q1 2026 | $78.1M | -20% |
| Q4 2025 | $88M | -12% |
| Q3 2025 | $92.6M | -6.7% |
| Q2 2025 | $93.5M | +0.4% |
| Q1 2025 | $97.3M | +13% |
| Q4 2024 | $99.8M | +11% |
HNST's revenue has slid since its 2024 peak: $85M last quarter, down 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | +1 points |
| Q2 2026 | 12% | +8.4 points |
| Q1 2026 | -0.8% | -3.4 points |
| Q4 2025 | -27% | -26 points |
| Q3 2025 | 0.3% | +0.3 points |
| Q2 2025 | 3.1% | +7.4 points |
| Q1 2025 | 2.6% | +4.1 points |
| Q4 2024 | -1% | -2.3 points |
HNST's operating margin was 1.4% last quarter, up 1 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over HNST on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over HNST on profitability, with a higher operating margin.
HNST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.8M | -$4.1M |
| Q2 2026 | $31.5M | +$32.3M |
| Q1 2026 | $3.8M | +$6.8M |
| Q4 2025 | $18.1M | +$35.2M |
| Q3 2025 | -$624K | -104% |
| Q2 2025 | -$826K | -128% |
| Q1 2025 | -$3M | -1254% |
| Q4 2024 | -$17.2M | -278% |
HNST has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
HNST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -627K shares |
| 1 year | -1.1% | -1.2M shares |
| 3 years | +18% | +17.3M shares |
| 5 years | +65% | +44.4M shares |
| Available history | +29% | +25.3M shares |
HNST has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.1M |
| Q2 2026 | $16.1M |
| Q1 2026 | $3M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
HNST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -9.4x | Net Cash |
| Q2 2025 | -9.9x | Net Cash |
| Q1 2025 | -218.7x | Net Cash |
HNST has more cash than debt.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
HNST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 34.6 | Neutral |
HNST's weekly RSI is 54 (neutral) and its Stochastic is 35 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
HNST PE vs Consumer Cyclical Sector
| Metric | HNST | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 18x | 61% below |
| PE % | 3 | 53 | 50 pts below |
HNST has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
HNST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.87 | 1.4% below |
| 20 week MA | $4.79 | 0.2% above |
| 50 week MA | $3.69 | 30% above |
| 100 week MA | $4.19 | 15% above |
| 200 week MA | $3.54 | 36% above |
HNST has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
HNST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.1 | $8.07 | -58% |
| 2022 | $8.07 | $2.97 | -63% |
| 2023 | $2.97 | $3.30 | +11% |
| 2024 | $3.30 | $6.93 | +110% |
| 2025 | $6.93 | $2.71 | -61% |
| 2026 YTD | $2.71 | $4.80 | +77% |
HNST has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.